SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO )
CNTO 0.000010000.0%Mar 7 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Howard Croy who wrote (58)3/18/1997 9:50:00 PM
From: FNS   of 965
 
Howard, I suspect the bio-techs will open higher tomorrow morning!!!
Whether the sell-off is over or not is unpredictable...the bio-techs have been slaughtered by heavy selling into the "good" news, i.e.; first, with FDA's approval of AGPH's new drug, and then taking down BGEN and CNTO, along with AGPH!

Picked up a 1000 shares at 35 5/8 last week hoping that the lower uptrend line would hold -- it didn't...but now I think the stock has a good chance to recover:

1. Monthly chart looks positive...shows ascending bottoms.

2. NASDAQ and Bio-techs approaching oversold conditions.

3. CNBC "BULL Session" sponsored both Merk and Centocor representatives to talk about their respective drugs to combat clotting in angina,etc.

Merk's drug has not yet been submitted for FDA approval but ReaPro application was submitted 2/18/97 with FDA approval expectation in 3Q97 according to Centocor. Session was positive for both companies, in my opinion.

Next support appears at 27-28; 20-21 if a major blowoff.

Personally, I believe in Centocor and will buy more to add as a core holding. Reapro has added up 3 years of data and hopefully will be a winner along with others...

good luck to all! FNS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext